Stelis Biopharma and Pieris, a next generation therapeutic protein R&D firm, have started a long-term collaboration for clinical development and commercialization of multiple novel Anticalin-based protein therapeutics worldwide, primarily ...
Global pharmaceutical company Zydus Cadila and Pieris, a therapeutic protein research and development company, have entered into an alliance for development and commercialization of multiple novel Anticalin-based protein therapeutics. The ...